View our
NEWSLETTER ARCHIVE
Email Marketing by Constant Contact®

 


Welcome to our website. 

"Legendary financial editor" Bob Flaherty rides again with his son Brian by his side. Flaherty is emphasizing over looked bargains of any size, especially promising micro and small-cap ventures to feel useful again. The decades have taught that happiness is a by product from serving others, and we will do our best to serve you. 

Please fill out the form and opt-in. As a subscriber you will receive our Flaherty Financial News and Flaherty Special Situation all electronic newsletters with an opt-in opt-out feature.  

Subscribe To Our Online Newsletters And Get Your Own Issues Directly In Your Email 

JOIN NOW

We are a digital content originator and electronic publisher of digital content. We cover publicly-traded companies & financial community events. We do news stories with hyperlinks to articles, company profiles and corporate videos. 

Real Financial Journalism That You Do Not See Everyday. The news stories we create ourselves will aim for objectivity, include risks and put our readers first. We will try to disclose our inevitable conflicts of interest. Because the small and mid-cap niches are neglected, we may be the only one writing about certain companies at any particular time. Stories about some subjects you will not find anywhere else. We try to search for overlooked quality companies and often succeed. 

We are a content-driven news organization, not a design-driven one. We are people with high standards and morals, and we expect the same from the people who choose to do business and interact with us.

Profiles? Yes, we specialize in writing stories and doing research on under-followed companies with upside potential. We know how to make company's come alive in words the ordinary investor can understand.   

Special Situations? Judged by two independent  outside ranking services, The Hulbert Financial Digest and Select Information Exchange, Editor Bob Flaherty has had one of the best long-term performances among all investment advisory newsletters. Because we miss the challenge of competition, we have started to make new picks again.   

HOW OUTSIDE SERVICES HAVE RANKED OUR PERFORMANCE. Bob Flaherty has built an enviable reputation as an early –bird stock picker who again and again uncovers overlooked special situation bargains often before TV’s talking heads or Wall Street’s big financial firms even know of their existence. His track record as measured by The Hulbert Financial Digest and Select Information Exchange is one few other financial newsletter writers have matched. Besides being editor of Equities magazine, Flaherty was editor of Equities Special Situations for 25 years. Bob was ranked No.1 for 14 consecutive months in Long Term Portfolio Gains among all Advisory Services measured by Select Information Exchange.

In a period during the following streak The Hulbert Financial Digest ranked Equities Special Situations #1 among any financial newsletter and #4 in the U.S. for stock performance. In several years Bob was first in his small cap category, according to The Hulbert Financial Digest, gaining an average of 1.7% in 2002, 76.5% in 2003, 16.1% in 2004 and 14.7% in 2005 versus -20.9%, 31.6%, 12.6% and 6.2% for the Wilshire 5000 Index Very few other newsletters have ever beaten their index for four consecutive years and also been up in a sharply down year like 2002. In 2006 Bob retired from Equities, which sadly appears to have slipped under the waves in stormy 2010, while his picks for 2006 were still ahead of the relevant averages. Mark Hulbert reports that over 80% of all advisory letters fail to beat the stock market over the long term. Naturally besides many big past winners, Bob has had a lot of strikeouts too because he swing for the fences, aiming for minimum gains of 50% to 100% over two years.   

All of our recent Flaherty Financial News and Flaherty Special Situation Newsletters have each been opened by about 1.5 million online investors with 13,000 to 24,000 clicks or more. Two have been opened by 3 million, including our CEL-SCI Flaherty Special Situation. That one resulted in a 25% increase in the stock price, generating over 48,000 clicks and increasing daily share trading by over 100,000 shares.  

Take a look around to learn more about the companies we are spotlighting and our insights. We invite you to become one of our friends in the financial community. -Brian Flaherty  


At the NASDAQ Market Site ItsAboutFinance.TV host Nicole Hunt interviews Bob Flaherty about 54 years in the investment trenches. 

54 years in the investment trenches

After graduating with a Distinction in Finance and an MBA from Harvard Business School in 1961 in addition to a Magna Cum Laude in Economics from Harvard College, Flaherty started out at Forbes where he retired as a senior editor in 1981. In between Bob wrote 33 cover stories, two shy of the magazine’s all time record. He reported favorably on tiny enterprises like Xerox and FedEx which grew to become household names. Besides his first New York Deadline Club Award from The Society of Professional Journalists in 1978, he is awarded the Amos Tuck Media Award for Economic Understanding for writing the best business story in any magazine. In 1979:  Flaherty is cited as outgoing president by the New York Financial Writers Association “for an outstanding performance in having returned us to a position of journalistic prominence.”

In 1984: Flaherty wins the Pannell Kerr Forster Award for Excellence in Financial Journalism for a story on unethical practices by abusive secret short sellers who destabilized companies by smearing  managements the shorts had targeted. The shorts would engage in prepublication trading by increasing their positions just before publication. His articles were credited by NASD President Gordon Macklin as leading to changes in monthly short selling reporting and many other reforms. Flaherty also wins a second Deadline Club Award from the Society of Professional Journalists for his expose of Denver penny stock scams in an article which was the first anywhere to print the nickname “Blind em and rob em “ of the notorious now defunct Blinder Robinson bucket shop.

The National Investor Relations Institute describes Flaherty as "One of the most respected financial journalist in the nation," while The Journalist and Financial Reporter includes Flaherty as one of the top 96 most influential financial journalists in the country. In 2006: U. S. Chamber of Commerce President Thomas Donohue dubbed Flaherty “the Mark Twain of America’s Capital Markets,” a comment Bob laughed was greatly exaggerated.


Our Treasure Chest of Ideas

Our annual “Favorites of the Famous” recommendations, started when Bob was editor of Equities magazine and continues today in a March issue of Flaherty Financial News Newsletter. The combined portfolio's of our panels of wise men and women have beaten  the S&P 500 18 out of 25 efforts, including a streak of 13 consecutive times. This is one of the best long-term track records of an annual  favorite stock feature anywhere on the planet. We get HIGH with the help of our friends. 


Photo Album

 

Brian D. Flaherty, President and Publisher
Flaherty Financial News Newsletter Publications

Flaherty Financial News Inc.
Phone: 914-539-0688 

Brian Flaherty is a LinkedIn member. For two people to connect, one must invite the other and then the other must accept the Invitation. If the person being invited to connect is not already on LinkedIn, they'll need to join in order to accept the Invitation. 
 
Brian's Public Profile:
 
 
Join Our Newsletter Mailing List: CLICK HERE

If you would like to submit some ideas for future newsletter subject matter contact:

Robert J. Flaherty
Editor and Chairman
Flaherty Financial News and Flaherty Special Situations
Bob@FlahertyFinancialNews.com 
Phone: 914-831-1151

We continue to spotlight overlooked bargains and unknown quality efforts with the help of our friends in the financial community. 


 John & Bob Loved To Exchange Ideas. 

Sir John's wisdom lives on: Our spiritual and financial pathfinder Sir John Templeton ( left ) exchanging ideas with editor Bob Flaherty has "gone home" as Sir John called dying. His wisdom lives on.

Look globally in every country for bargains. Seek the least popular and bests buys as measured by comparative price- earnings ratios and other value screens. Be contrarian. When nearly everyone thinks and acts quarterly, have the discipline to look out at least three years and buy what will become popular again. Take profits and invest some of your gains in new bargains. Be humble! When you make a mistake admit it as quickly as possible. Diversify by industry, investment style and especially geographic region. In this unpredictable world, no more than 25% of your equity holdings should be invested in the stocks of any one country, especially your own. Don't sit on too much cash. Remember you will never live to see a year when a U.S. dollar will buy in December as much as it did in January! Above all, be optimistic for the long run. Don't waste time worrying. In the short run try to turn every negative into a positive. Stress positive thinking! Have purpose. Everyday focus on what is positive and productive. See opportunities you would of missed. Happiness can not be found by seeking it directly. It is a by product of living a life of serving others. 


Digital Copyright © 2015 Flaherty Financial News Inc. All Rights Reserved




International investors flew from Medellin over 500 miles deeper toward the Columbian border with Ecuador before transferring to military helicopters which landed guided by brush fires lit by heavily armed soldiers. Everyone exiting, including South American Gold President Ray De Motte (left) and Editor Bob Flaherty (right) , was ordered to keep moving quickly because FARC guerillas were rumored to be in the area. Next came a bumpy winding ride up around a mountain to South American Gold's (SAGD.OB) initial Santacruz Gold Project in the least explored most dangerous and therefore least picked over part of Columbia. Alas SAGD terminated the venture but the ride was fun.

 



OUR THRILLING EXPERIMENTAL RESPONSES!

We experiment to get spectacular response. We featured enhanced CEO conference presentations to very small groups in highly readable old Forbes short story style snapshots.
Flaherty Financial News Newsletters
sends these profiles out to over 20 million opt-in U.S. online investors. About 1.5 million open the the issue with 13,000 to 24,000 clicks or more.  
Our sister Flaherty Special Situation Newsletter, which turns out much longer BUY reports, was sent to over 92 million opt-in investors in the U.S., Canada and the U.K. with impresive results. Over 6 million online investors opened our issue featuring CEL-SCI Corp. with over 96,000 clicks. During our month-long program, average daily share trading increased significantly. So did the share price! At 81 Bob felt a thrill hitting one more pitch out of ballpark! Please consider making your company or fund one of our snapshot profiles or a BUY report in an upcoming issue.
  

 




April 22, 2015
UPDATED DIGEST
Flaherty Financial News Newsletter #46
Big news for Mexico and Latin America.

Click Here Direct Link To UPDATE


March 30,2015
Flaherty Financial News Newsletter #49
Flaherty's Favorites of the Famous with a lucky 13 New Picks Larry's liver -saver vaccine. Mario's head is in the clouds. Rogers prefers down to earth money men. Lauren dines on pork in Hong Kong while hubby Scott finds an oil play. Makepeace sticks with his Blood-in-the-streets Russian P/E of 3 pick. Bob's mother of all biotech credibility gaps. Russ has high hopes.

Click Here Direct Link To Report


February 24, 2015
Flaherty Special Situation Newsletter #38
CEL-SCI (NYSE: CVM) is the most undervalued Phase lll biotech in America. This turnaround aims to enroll 880 head and neck cancer patients in over 100 sites in at least 21 countries before yearend. Success in this global Phase III trial of its lead immunotherapy drug regime Multikine could be rewarded with a one day stock jump of $ billions. Other tantalizing possibilities exist for HPV and rheumatoid arthritis. Dreamer CEO Geert Kersten and his outstanding team are building a keeper.

Click Here Direct Link To Report


January 13, 2015
Flaherty Financial News Newsletter #48
Six Promising Medical Breakthroughs at Bargain Prices!
After the January dip, thrilling medical breakthroughs efforts from Rodman & Renshaw's fall conference sell at bargain prices. CEO snapshots of APDN, CFRX, HTBX, NBY, NURO and ONCS.

Click Here Direct Link To Report


December 13, 2014
Flaherty Financial News Newsletter #47
A Very Bullish 2015!
Singular Research's Bob Maltbie's very bullish on 2015! Two sleepers - INTL and YGYI - from its "Best of the Uncovereds Conference." From SeeThruEquity: PESI to the rescue and ARTH will stop bleeding after surgery or injury in seconds versus minutes today.

Click Here Direct Link To Report


November 20, 2014
Flaherty Special Situation Newsletter #37
BioSig Technologies (OTCQB: BSGM) is revolutionizing the recording of abnormal heartbeat wave signals to improve innovation - starved arrhythmia treatment. Cardiac electrophysiologists who monitor and correct electrical activity of the heart need cleaner, clearer, real time intra-cardiac within the heart recording. Success should bring improved better results for thousands of patients, shorter operations, reduction of unacceptably high recurrence procedures and lower costs. Follow Up: Remembering the fairy tale life of one of America's first female financial writers courageous Clare Reckert. The New York Times' first female financial writer and it's first to get a Times' byline, Clare had to misspell her first name Claire without an (i). A male boss wanted readers to think she was a man. Her efforts for gender parity at The New York Times infuriated the males so much her passing at age 100 didn't receive even a single line of obit in the print edition of the paper. Way to go guys!

Click Here Direct Link To Report


SEE APRIL 22, 2015 UPDATE
October 9, 2014
Flaherty Financial News Newsletter #46
Stevia First Corp. (STVF): Now open for business with all-natural, safer, sweeter-than-sugar stevia. An important deal gives this research-oriented startup the opportunity for commercial sales and positive cash flow. Developing even sweeter next-gen stevia products.

Click Here Direct Link To Report


September 2, 2014
Flaherty Financial News Newsletter #45
Five Promising CEO Presentation Snapshots.
Turnarounds at Cryoport (CYRX) and Carmanah Technologies (CMH.TO). Follow up: Progress at Champions Oncology's (CSBR) breeding your own lifesaving avatar mouse and a Nasdaq listing for Fusion Telecommunications (FSNN)! Also: "About Harvard's Dave What's-His-Name?"

Click Here Direct Link To Report


March 10, 2014
Flaherty Financial News Newsletter #41
CEO Profile Snapshots: Fine tuning Dan Lufkin's crusade to identify deadly melanoma earlier at MELA Sciences, Inc.! Jeremy Barbera's start-up Vantage Health Inc. (VNTH) licenses NASA space telemedical technology to enable your smart phone to detect lung cancer before it is too late.

Click Here Direct Link To Report


July 23, 2013
Flaherty Financial News Newsletter #37
An update on CORT's unfinmished crusade to offset morbid obesity and other deadly side effects afflicting millions of mental patients and stressed veterans relying on our five major antipsychotic drugs.

Click Here Direct Link To The Report


September 11, 2011
Flaherty Financial News Newsletter #28
A tear for the friends we lost in 9-11.
Corcept Therapeutics Inc. (NASDAQ: CORT) tackles the single biggest dilemma in psychiatry. Antipsychotic drugs stabilize mental patients, but with harmful metabolic side effects of morbid obesity, arterial heart disease, stroke and Type 2 diabetes.

Click Direct Link To Report


Updated August 17, 2011
June 21, 2011
Flaherty Special Situation #25 
At OncoSec Medical Incorporated (ONCS.OB) an experienced team with money raising know how and two products. One kills cancer cell: The other strengthens immune responses capable of killing cancer cells.

Click Direct Link To Report


February 2, 2011
Flaherty Financial News
Newsletter #25
Expose Part 12: The Return of The Invisible Man Jason Galanis; Mission Accomplished!

Click Direct Link To Report





 

Companies with Archived Coverage: 2015 -2014

 A.K. Transneft (TRNFP.ME), Ambit Biosciences Corp. (Nasdaq:AMBI), Applied DNA Sciences, Inc. (Nasdaq:APDN), ArcelorMittal (NYSE ADR: MT), Arch Therapeutics, Inc.  (OTC: ARSD), BDCA Venture Inc. (Nasdaq:BDCV) formerly Keating Capital, BioSig Technologies, Inc.  (OTC:BSGM),  BM&F Bovespa (BVMF:BVMF3) , Bovie Medical (NYSEAmex: BVX),  Carmanah Technologies Corp. (CMH.TO) , CEL-SCI Corporation  Champions Oncology  (OTC:SCBR)  , Chemtura Corp. (NYSE:CHMT) ,  Churchill Downs, Inc. (Nasdaq) , ContraFect Corporation (Nasdaq:CTRX), Corcept Therapeutics (Nasdaq:CORT), CoverAll Technologies (NYSE:COVR),  Cryoport Inc. (OTC:CYRX) ,  Dynavac Technologies (Nasdaq:DVAX) ,  Ergomed Plc. (ERGO.L)  , Fabrinet (NYSE:FN) , Fairfax Financial Holdings (OTC:FRFHF), Fairway Group Holdings Corp. (Nasdaq:FWM) , FONU2 (OTC:FONU), FRP HOLDINGS (Nasdaq:FRPH), FUJIFILM HOLDINGS CORP. (OTC:FUJIY), Fusion Telecommunications International (Nasdaq:FSSN), Graphite One Resources (GPH.V), HALLMARK FINANCIAL SERVICES (Nasdaq:HALL), Heat Biologics, Inc.  (Nasdaq:HTBX), Inovio Pharmaceuticals, Inc. (Nasdaq:INO), INTL FCStone Inc.  (Nasdaq:INTL), International Game Technology (NYSE:IGT), International Speedway Corporation (OTC:ISCB) , INTERNAP NETWORK SERVICES (Nasdaq:INAP), Kia Motors Corp. (000270), lAZARD LTD. (NYSE:LAZ), Moon River Studios, formerly Medient Studios (OTC:MDNT) , MELA Sciences Inc. (Nasdaq: MELA) , NEUTRAL STEM (NYSE:CUR), NeuroMetrix, Inc. (Nasdaq:NURO),  NovaBay Pharmaceuticals, Inc. (NYSE:NBY) , OncoSec Medical Inc.(OTC: ONCS) , Patriot Transportation Holding, Inc. (Nasdaq:PATR & NOW PATI), Perma-Fix Environmental Services Inc.  (Nasdaq: PESI), Qualcomm Inc. (Nasdaq:QCOM), RENN Global Entrepreneurs Fund (NYSE:RCG), SandRidge Energy (NYSE:SD), Stevia First Corp. (OTC: STVF), Teva Pharmaceuticals, Tonix Pharmaceuticals (Nasdaq:TNXP), Trex Company (NYSE:TREX), Trulia, Inc. acquired by Zillow Group (Nasdaq:Z), Vantage mHealthcare, Inc.  (OTC: VNTH), Youngevity International, Inc. (OTC: YGYI), WH GROUP (0288.HK), ZILLOW GROUP (Nasdaq:Z).

Golden Oldies:  July 13, 2007 - our very first issue of Flaherty Financial News issue:  Pre-Paid Legal Services Inc. is a classic case history on how to defeat abusive short sellers.

See our Feb. 2, 2011 “Mission Accomplished!” Big time media finally picked up our reporting. Thanks guys and gals! This issue concluded our 12- issue, 15-month expose which commenced in Oct. 4, 2009 with: “The Invisible Man Returns:  Jason Galanis Reappears.”  Also see Expose part Ten: The Invisible Man doesn’t appear in his active ETF IPO prospectuses.   The expose companies featured   Fund.com Inc.  (FNDM.PK) and GEROVA Financial (NYSE:GFC) both subsequently collapsed. 

See our Nov. 29, 2009 “Our missing angel goes home” – a salute to financial writer Phyllis Feinberg. Also in that issue “Woof, Woof for Mantra Venture Group (MVTG).  

Disclaimer- Flaherty Financial News Inc. Charges for some of our services such as advertising, audience distribution, conference presentations, sponsored profiles, sponsored special situation buy reports and PDF reprints. Where we have conflicts we will disclose our receipts of cash or stock in the relevant newsletter and update any additional payments decided upon afterwards as they occur in subsequent issues. This is a hybrid journalistic effort where some copy is sponsored and some is not.   

This website and our archived newsletters contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. We caution readers not to place undue reliance on any forward-looking statements and to supplement our information with specific company SEC filings and their own research. Please be aware that there is risk in every company you buy and the smaller the company, usually the greater the risk. Coverage or other mention of a stock on this website or in a newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. We are not investment dealers or investor advisers registered with the SEC or State Security Authorities. We do not guarantee all the information on this website or in any FFN newsletter is correct, timely or will be updated. Remember some errors are inevitable. Reproduction without written permission from FFN is forbidden. From time to time our staff or Flaherty Financial News Inc. may be a shareholder of any individual company profiled in our newsletters or named on our website. Our editorial policy forbids editorial from buying or selling any stock mentioned in a particular issue until this particular issue is out at least ten business days. In cases where FFN receives compensation for writing a profile or report or for extra distribution we warn that such sponsored coverage becomes similar to an advertorial and does not have the same degree of independence as unpaid unsponsored coverage. As FFN editor I always reserve “Final Copy Responsibility” on what to include and what to leave out of every article and report. We try to be objective, but may fail. We are not security analysts or stockbrokers but financial journalists with all the failings of that profession. You readers must decide the merits of each company yourselves and whether it is suitable for you as an investment. Bob Flaherty, Editor.    

Flaherty Financial News Inc. (FFN) and its newsletters Flaherty Financial News and Flaherty Special Situations are not registered as broker dealers or investment advisers with the U.S. Securities and Exchange Commission or any state securities authority. Our newsletters and their information and content providers make no representations or warranties of any kind in connection with the subject matter, performance or suitability of the information contained in the publications for any purpose and are not liable for the timeliness, accuracy or completeness of the information. The information is provided for general information purposes and is not a substitute for obtaining professional advice from a qualified person or entity familiar with your personal circumstances. Please seek the help and advice of professionals as appropriate regarding the evaluations of any specific security, report, opinion, advice or other content. FFN is not responsible for trades placed by recipients. All opinions expressed, information and date provided are subject to change without notice. FFN, its officers and its employees may have positions in and may from time to time make purchases or sales of the securities discussed or mentioned by FFN. (However, we will avoid front running and the buying or selling of any security about to be discussed until ten business days after our particular report is released to the public.) FFN shall have no liability for any newsletter that is lost, intercepted or not received in a timely manner, or not received at all, for any reason.

Digital Copyright © 2015 Flaherty Financial News Inc. All Rights Reserved